Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 213 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer

 		Prostatic Neoplasms, Castration-Resistant Phase 1 Australia
South Africa

Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs

 		Gastroenteropancreatic Neuroendocrine Tumors, Pheochromocytoma, Paraganglioma Phase 2 Italy
France
United States
Canada
Spain
Poland
Netherlands
United Kingdom
Belgium
View All

Post-Authorization Safety Study (PASS) of LysaKare® in Adult Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients

 		Gastroenteropancreatic Neuroendocrine Tumors Phase 4 Netherlands
Poland
Italy
United Kingdom
View All

[177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-NeoB Lesion Uptake

 		Neoplasms Phase 1, Phase 2 United Kingdom
United States
Netherlands
Austria
Spain
View All

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

 		Spinal Muscular Atrophy (SMA) United States
Russian Federation
Japan
Portugal
Ireland
Greece
Taiwan
Korea, Republic of
Israel
View All

A Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo and With Omalizumab as Active Control in CSU Adult Patients.

 		Chronic Spontaneous Urticaria Phase 3 Turkey
Australia
Switzerland

A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease

 		Coronary Heart Disease Phase 2 United States

A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever

 		Dengue Phase 2 Singapore

Characterizing Guideline Adoption and Treatment Quality in Clinical Routine of German HFrEF Care

 		Heart Failure Germany

A Randomized, Double-blind 2-arm NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.

 		Sjogrens Syndrome Phase 3 Poland
Australia
Japan
Hungary
Czech Republic
Slovakia
View All